ROCK & ASSOCIATES for WOMEN'S INTERNATIONAL PHARMACY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S.2437.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Health Issues HCR
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Law Enforcement/Crime/Criminal Justice LAW
Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.